VBVagarshak V. Begoyan

Vagarshak V. Begoyan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vagarshak V. Begoyan has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Coumarins: Spectroscopic measurements and first principles calculations of C4‐substituted 7‐aminocoumarins

    by Shraddha Singh, Vagarshak V. Begoyan, Marina Tanasova, Kevin Waters, Max Seel, Ravindra Pandey

    Coumarins are widely applied in sensing devices due to their diverse fluorescence properties. In this paper, we consider the C4‐substituted 7‐aminocoumarins to investigate the structure‐property relationship via examining the effect of the various substitutions on their optical properties. Absorption and fluorescence measurements together with time‐dependent density functional theory calculations are described. We find that the significant red shift in the fluorescence spectra is associated with the cyclic carbonyl group of coumarins due to a substantial increase in the dipole moment in the photoexcited state. The apparent correlation between experimental and calculated results provides an atomistic‐level insight into the role of the functionality at the C4 of coumarins and sets the basis for using computational analysis to predict the fluorescence properties of coumarins.


  • Open Access

    Metabolism-Driven High-Throughput Cancer Identification with GLUT5-Specific Molecular Probes

    by Srinivas Kannan, Vagarshak V. Begoyan, Joseph R. Fedie, Shuai Xia, Łukasz J. Weseliński, Marina Tanasova, Smitha Rao

    Point-of-care applications rely on biomedical sensors to enable rapid detection with high sensitivity and selectivity. Despite advances in sensor development, there are challenges in cancer diagnostics. Detection of biomarkers, cell receptors, circulating tumor cells, gene identification, and fluorescent tagging are time-consuming due to the sample preparation and response time involved. Here, we present a novel approach to target the enhanced metabolism in breast cancers for rapid detection using fluorescent imaging. Fluorescent analogs of fructose target the fructose-specific transporter GLUT5 in breast cancers and have limited to no response from normal cells. These analogs demonstrate a marked difference in adenocarcinoma and premalignant cells leading to a novel detection approach. The vastly different uptake kinetics of the analogs yields two unique signatures for each cell type. We used normal breast cells MCF10A, adenocarcinoma cells MCF7, and premalignant cells MCF10AneoT, with hepatocellular carcinoma cells HepG2 as the negative control. Our data indicated that MCF10AneoT and MCF7 cells had an observable difference in response to only one of the analogs. The response, observed as fluorescence intensity, leads to a two-point assessment of the cells in any sample. Since the treatment time is 10 min, there is potential for use in rapid on-site high-throughput diagnostics.


  • Multicolor GLUT5-permeable fluorescent probes for fructose transport analysis

    by V. V. Begoyan, Ł. J. Weseliński, S. Xia, J. Fedie, S. Kannan, A. Ferrier, S. Rao, M. Tanasova

    A set of coumarin-based fluorescent sugar conjugates – ManCous is reported. ManCous are specific for fructose transporter GLUT5 and cover a broad range of the fluorescence spectrum providing essential tools for the evaluation of fructose transport capacity in live cells.


  • Fructose uptake-based rapid detection of breast cancer

    by Joseph Fedie, Srinivas Kannan, Vagarshak Begoyan, Shuai Xia, Suhel Shaikh, Marina Tanasova, Smitha Rao

    Rapid detection of carcinogenesis is the holy grail in timely cancer detection and point-of-care applications. Realization of these applications has been hampered by lack of specificity and/or selectivity of biomarkers and the low concentrations at which the biomarkers are available. A majority of the detection technologies rely on cell-receptor interactions, activation of specific receptors, gene identification and fluorescent tagging. All these techniques are time consuming and often require specialized equipment. Here we present a method to use the enhanced metabolism in breast cancer that relies on fructose for nutrition. Using fluorescent-labeled fructose analogs as reporter probes, we have demonstrated that cancer cells can be optically identified in a very short time due to the efficient internalization of the probe by cancer cells through the fructose-specific transporter. In our trials using breast cancer and normal cells, we were able to show an eight-times higher fluorescence in cancer cells compared to basal uptake in normal within 10 minutes. The cancer cells were distinguishable from normal cells by monitoring the accumulation of the coumarin-induced fluorescence using a conventional microscope and simple image processing.


  • Open Access

    Tuning Cross-Coupling Approaches to C3 Modification of 3-Deazapurines

    by Łukasz J. Weseliński, Vagarshak Begoyan, Alexis Ferrier, Marina Tanasova

    A general approach to C3 modification of purine scaffold through various types of cross-coupling reactions has been established. Tuning substrate electronics and reaction conditions resulted in the development of highly efficient sp2–sp, sp2–sp2, and sp2–sp3 cross-coupling conditions for modification of 3-deazaadenine to access C3-modified adenine and hypoxanthine scaffolds. The optimized methodologies to access the corresponding 3-deazaadenosine phosphoramidites for solid-phase DNA synthesis have been demonstrated.